Quantum Genesis AI Corp. (OTC: QGAI) on May 19, 2026 issued a statement to clarify certain disclosures regarding its research activities and intellectual property, seeking to distinguish the company from Quantumzyme LLP, a separate entity based in Bengaluru, India. The company emphasized that Quantumzyme LLP is not a subsidiary or affiliate of Quantum Genesis AI.
The clarification follows prior press releases on November 5, 2025 and February 12, 2026 that referenced scientific publications related to the company's enzyme engineering and biocatalysis field. Those publications identified Quantumzyme LLP and reflected the affiliations of contributing researchers at the time the research was conducted and submitted. Quantum Genesis AI now aims to provide additional context about the intellectual property and technology rights previously transferred to the company under an Asset Purchase Agreement dated February 21, 2023, and a subsequent confirmatory assignment.
According to the company, scientific publications arising from research activities undertaken by its Chief Executive Officer, Naveen Kulkarni, appropriately reflect the affiliations of the contributing researchers at the time of submission. However, the company believes that the Asset Purchase Agreement transferred underlying technology, methodologies, computational approaches, know-how, and related intellectual property associated with its core enzyme engineering and biocatalysis business.
As disclosed in the company's Current Report on Form 8-K filed on April 29, 2026, the company entered into a confirmatory assignment relating to certain intellectual property and technology associated with its enzyme engineering and biocatalysis platform. The company asserts that to the extent research activities conducted by Mr. Kulkarni, whether directly or through Quantumzyme LLP, relate to the company's core field and are based on or derived from the transferred technology platform, such intellectual property falls within the scope of the rights transferred to the company.
Quantum Genesis AI Corp. is focused on advancing technologies at the intersection of artificial intelligence, computational modeling, and scientific innovation. The company's strategy includes leveraging data-driven tools to support research and development across emerging sectors while maintaining transparency and responsible governance. For more information, visit www.qgaicorp.com and the company's profile at www.otcmarkets.com/stock/QGAI.
